Vaccine Laboratory has been established
to ensure that the vaccines produced, distributed and
imported into the country are safe, efficacious and potent with the
mandate to evaluate and ensure the quality of Biologicals referred to
To develop linkage with other national/international institution and
keep abreast with worldwide scientific research and technological
developments in production and quality control of vaccine with a view to advising on the suitability of their adoption.
To develop technical guidelines/ manuals on standards to be used by
manufacturers and to undertake research on various immunobiologicals using
multidisciplinary integrated approach.
Providing training facilities in quality control testing of vaccines
for personnel of related institutions including testing and
manufacturing units and six month dissertation project for post graduate
students (M.Sc &B.Tech) of various universities is also formed as an
indispensable part of its activities.
Vaccine & Antisera Laboratory is notified as CDL for the BCG Vaccine, Cell Culture Rabies Vaccine, Live attenuated Measles Vaccine, Live Attenuated Rubella Vaccine. (Ref. Gazette Notification No: G.S.R. 250 (E) - Part-II - Section 3 - Sub-Section (i) dated 15.03.2017) and Oral Polio Vaccine (Ref. Gazette Notification No: G.S.R. 249 (E), dated: 04.04.2002).
Lab has taken up collaborative studies such as inclusion of WHO protocol for Determination of PRP content of Hib (Haemophilus Influenzae type b) in liquid vaccine presentations by HPAEC-PAD in Indian Pharmacopoeia. The purpose of such study was to optimize the protocol for final validation studies and bringing the stakeholders on common consensus for final inclusion of WHO protocol in Indian Pharmacopoeia.